 Provider News GeorgiaSeptember 2021 Anthem Provider News - Georgia
Join us in a Continuing Medical Education (CME) webinar series as we share practices and success stories to overcoming barriers in achieving clinical quality goals, attaining better patient outcomes and improving STARs ratings.
Program objectives:
- Learn strategies to help you and your healthcare team improve your performance across a range of clinical areas.
- Apply the knowledge you gain from the webinars to improve your organization’s quality and STARs ratings.
Attendees will receive one CME credit upon completion of a program evaluation at the conclusion of each webinar.
REGISTER HERE for our upcoming clinical quality webinars!
Material adverse change (MAC)
AIM Specialty Health®
AIM Specialty Health®, a separate company, is a nationally recognized leader delivering specialty benefits management on behalf of Anthem for certain health plan members. Determine if prior authorization is needed for a Georgia Anthem member by visiting the “Medical Policy and Clinical UM Guidelines” page on our provider website or by calling the prior authorization phone number printed on the back of the member’s ID card. To submit your request for any of the services below, contact AIM online via AIM’s website at aimspecialtyhealth.com/goweb. From the drop-down menu, select GA. You may also call AIM toll-free at 866-714-1103, Monday–Friday, 8:00 a.m.–6:00 p.m. ET
AIM provides benefits management for the programs listed below:
- Imaging level of care
- Genetic testing
- Diagnostic imaging management
- Cardiovascular services
- Radiation therapy services
- Rehabilitative services
- Outpatient sleep testing and therapy services
- Cancer care quality program
- Musculoskeletal (for fully insured)
- Upper gastrointestinal endoscopy in adults, and site of care for certain surgical services
For more details on these programs, please visit the AIM website. By clicking on the previous links, you will be directed to sites created and/or maintained by another, separate entity (“external site”). Upon linking you are subject to the terms of use, privacy, copyright and security policies of the external sites. We provide these links solely for your information and convenience. We encourage you to review the privacy practices of the external sites. The information contained on the external sites should not be interpreted as medical advice or treatment provided by us.
Eligibility and benefits
Eligibility and benefits can be verified on anthem.com/provider or by calling the number on the back of the member’s identification card. Service preapproval is based on member’s benefit plan/eligibility at the time the service is reviewed/approved. Benefit plans vary widely and are subject to change based on the contract effective dates. The provider is responsible for verification of member eligibility and covered benefits. Except in the case of an emergency, failure to obtain preapproval prior to rendering the designated services listed below will result in denial of reimbursement.
Add to preapproval
|
CG-MED-59
Upper Gastrointestinal Endoscopy in Adults
|
0652T, 0653T, 0654T
|
Added 7/1/2021 (New Codes)
|
TRANS.00025
Laboratory Testing as an Aid in the Diagnosis of Heart Transplant Rejection
|
0055U, 0087U, 0118U
|
Added 12/01/2021
|
Adults 40–75 years of age with diabetes, who do or do not have clinical atherosclerotic cardiovascular disease (ASCVD), should be started on a statin for primary and secondary prevention of ASCVD regardless of lipid status .1
Studies show that statin use reduces comorbidities and mortality from heart disease and non-adherence to statins may increase cardiovascular events and even death.2
Clinicians play a powerful role in ensuring their patients are adherent to their statin therapies. In fact, 90% of patients can be successfully adherent to statin therapy with a personalized approach.
We created this video to offer clinicians best practices in helping their patients remain adherent to their statin therapies.
The following 7 strategies can help increase adherence to statin therapy in your patients:
- Initiate statin therapy for patients with diabetes or clinical ASCVD as appropriate
- For diabetics without ASCVD, use MODERATE INTENSITY statin for primary prevention.2
- For diabetics with ASCVD, use HIGH INTENSITY statin for secondary prevention.1
- Low Intensity statins are not recommended unless unable to tolerate moderate or high intensity.4
Medications
One of the following medications must have be dispensed to satisfy the SUPD measure.
|
Drug Category
|
Medications
|
Statin medication
|
· Lovastatin
· Fluvastatin
· Pravastatin
· Simvastatin
· Rosuvastatin
· Atorvastatin
· Pitavastatin
|
Statin combination products
|
· Atorvastatin / amlodipine
· Atorvastatin / ezetimibe
· Lovastatin / niacin
· Simvastatin / ezetimibe
· Simvastatin / niacin
· Simvastatin / sitagliptin
|
Timeframe
|
Standard exclusion(s)
|
Any time during the measurement year
|
· End-stage renal disease
· Hospice
· Rhabdomyolysis or myopathy
· Pregnancy, lactation, or fertility
· Liver disease
· Pre-diabetes
· Polycystic ovary syndrome (PCOS)
|
|
|
- If a statin is not suitable for a patient, document exclusion criteria with the appropriate ICD-10 code
- Educate patients about the long-term cardiovascular benefits of statin therapy and potential side effects
- Try a lower dose, different statin, or consider intermittent statin therapy if there were previous statin-associated side effects
Intensity and Dose of Statin Therapy
|
High Intensity
|
Moderate Intensity
|
Low Intensity
|
5. Daily dose lowers LDL-C on average by ≈ ≥50%
|
6. Daily dose lowers LDL-C on average by ≈ 30% to <50%
|
7. Daily dose lowers LDL-C on average by <30%
|
8. Atorvastatin 40-80 mg
9. Rosuvastatin 20-40 mg
|
10. Atorvastatin 10-20 mg
11. Rosuvastatin 5-10 mg
12. Simvastatin 20-40 mg
13. Pravastatin 40-80 mg
14. Lovastatin 40 mg
15. Fluvastatin XL 80 mg
16. Fluvastatin 40 mg bid
17. Pitavastatin 2-4 mg
|
18. Simvastatin 10 mg
19. Pravastatin 10-20 mg
20. Lovastatin 20 mg
21. Fluvastatin 20-40 mg
22. Pitavastatin 1 mg
|
- Inform patients that a significant number of generic statin medications are available for $0 for a 90-day supply on most plans
- Encourage patients to use their plan ID card to fill statin medications
- Watch this video to learn best practices on helping improve statin therapy adherence and your organization’s overall quality and STARS performance.
Instead of faxing multiple pages of medical records for HEDIS® studies, use Anthem’s Remote EMR Access Service we offer to providers that allows us to access your EMR system directly to pull the documentation we need. Our Remote EMR Access Service helps reduce the time and costs associated with medical record retrieval while improving efficiency and lessening the impact on your office staff.
We have a centralized EMR team experienced with multiple EMR systems and extensively trained annually on HIPAA, EMR systems, and HEDIS® measure updates. We complete medical record retrieval based on minimum necessary guidelines:
- We only access medical records of members pulled into the HEDIS® sample using specific demographic data.
- We only retrieve the medical records that have evidence related to the HEDIS® measures.
- We only view face sheets when there are demographic discrepancies.
- We exclude data related to hospice, long-term care, inpatient, and palliative care.
Let us help you! Getting started with Remote EMR Access is just one click away.
Download and complete this registration form and email it to us at Centralized_EMR_Team@anthem.com.
To learn more about our Remote EMR Access Service, view the Frequently Asked Questions below.
How do you retrieve our medical records? We access your EMR using a secure portal and retrieve only the necessary documentation by printing to an electronic file we store internally, on our secure network drives.
Is printing necessary? Yes. The NCQA audit requires print-to-file access.
Is this process secure?Yes. We only use secure internal resources to access your EMR systems. All retrieved records are stored on Anthem’s secure network drives.
Why does Anthem need full access to the entire medical record?There are several reasons we need to look at the entire medical record of a member:
- HEDIS® measures can include up to a 10-year look back at a member’s information.
- Medical record data for HEDIS® compliance may come from several different areas of the EMR system, including labs, radiology, surgeries, inpatient stays, outpatient visits, and case management.
- Compliant data may be documented or housed in a non-standard format, such as an in-office lab slip scanned into miscellaneous documents
What information do I need to submit to use your Remote EMR Access Service?
- Complete the registration form that requests the following information:
- Practice/facility demographic information (e.g., address, National Provider ID, taxpayer identification numbers, etc.)
- EMR system information (e.g., type of EMR system, required access forms, access type – web based or VPN-to-VPN connection, special requirements needed for access, etc.)
- List of current providers/locations or a website for accessing this list. Also, if applicable, a list of providers affiliated with the group that are not in the EMR System.
Did you know the cost Impact of medication non-adherence is $528 billion from non-optimized medication therapy? 1 That’s equivalent to 16% of U.S. total health expenditures and contributes to 275,689 deaths per year. 2
As a healthcare provider, you can motivate your patients to adhere to their medication regimens, which can contribute to improved outcomes and increased STARS performance.
We developed this video to offer best practices in boosting medication adherence among your patient population.
Use the 6 SIMPLE strategies below to help improve medication adherence among your patient population.
S - Simplify the regimen
- Limit the # of doses and frequency
- Encourage adherence aids such as a pill box
- Utilize generic prescriptions if clinically appropriate
- Implement real-time pharmacy benefit to understand patient cost-share at the point of care
I - Impart knowledge
- Assess patient’s knowledge of medication regimen
- Provide clear medication instructions (written and verbal)
- Patient-provider shared decision-making
M - Modify patient beliefs and behavior
- Ask open ended questions about impact of not taking medications
- Empower patients to self-manage their condition
P - Provide communication and trust
- Provide emotional support
- Allow adequate time for the patient to ask question
L - Leave the bias
- Understand patient’s health literacy and how it affects outcomes
- Develop a patient-centered communication styles
E - Evaluate Adherence
- Utilize motivational interviewing to confirm adherence
- Review pharmacy refill records, Rx bottles, lab testing
- Identify barriers to adherence
- Determine interventions and follow-up
- When appropriate, prescribe 90 day fills for chronic conditions
Watch this video to learn more best practices on helping improve medication adherence and your organization’s overall quality and STARS performance.
A mother has a sick child and like all good mothers, wants comfort and care. And a prescription for antibiotics. BMJ Journals published a study that rated how many patients with upper respiratory infections (URI) prior to consultation with their physician expected a prescription for antibiotics.
Evidence-based data does not support the use of antibiotics in the treatment of the common cold because they do not improve symptoms or shorten the course of the illness. Instead of putting away the prescription pad, use this one.

Offered by the CDC’s Be Antibiotics Aware campaign, the “Relief for common symptoms of colds and cough” prescription pad provides an alternative to unnecessary antibiotics. Get it through the CDC website here.

Measure up: HEDIS® guidelines for URI/Pharyngitis
URI measures the percentage of episodes for members 3 months of age and older with a URI diagnosis that did not result in an antibiotic dispensing event.
Appropriate Testing for Pharyngitis (CWP) evaluates members 3 years of age and older where the member was diagnosed with pharyngitis, dispensed an antibiotic and received a group A streptococcus (strep) test for the episode.
Records and billing codes
URI: In the patient’s medical records, document results of all strep tests or refusal for testing. If antibiotics are prescribed for another condition, take care to associate the antibiotic with the appropriate diagnosis.

CWI: In the patient’s medical records, document results of all strep tests or refusal for testing. If antibiotics are prescribed for another condition, take care to associate the antibiotic with the appropriate diagnosis.

Effective November 1, 2021, EnrollSafe will replace CAQH Enrollhub as the electronic funds transfer (EFT) enrollment portal for Anthem providers. As of November 1, 2021, CAQH Enrollhub will no longer offer EFT enrollment to new users.
When you sign up for EFT through EnrollSafe, the new enrollment portal, you’ll receive your payments up to seven days sooner than through the paper check method. Not only is receiving your payment more convenient, so is signing up for EFT. What’s more, it’s easier to reconcile your direct deposits.
EnrollSafe is safe, secure and available 24-hours a day.
Beginning November 1, 2021, log onto the EnrollSafe enrollment hub at enrollsafe.payeehub.org to enroll in EFT. You’ll be directed through the EnrollSafe secure portal to the enrollment page, where you’ll provide the required information to receive direct payment deposits.
Already enrolled in EFT through CAQH Enrollhub?
If you’re already enrolled in EFT through CAQH Enrollhub, no action is needed unless making changes. Your EFT enrollment information will not change as a result of the new enrollment hub.
If you have changes to make, after October 31, 2021, use EnrollSafe to update your account.
Electronic remittance advice (ERA) makes reconciling your EFT payment easy and paper-free. Now that you are enrolled in EFT, using the digital ERA is the very best way to reconcile your deposits – securely and safely. You’ll be issued a trace number with your EFT deposit that matches up with your ERA on Availity.
ERAs can be retrieved directly from Availity. Log onto Availity and select Claims and Payments > Send and Receive EDI Files > Received Files folder. When using a clearinghouse or billing service, they will supply the 835 ERA for you. You also have the option to view or download a copy of the Remittance Advice under Payer Spaces > Remittance Inquiry tool.
Material adverse change (MAC)
Beginning with dates of service on or after December 1, 2021, Anthem Blue Cross and Blue Shield (Anthem) will implement a new reimbursement policy titled Sexually Transmitted Infections Testing. Anthem considers sexually transmitted infection (STI) testing CPT® codes 87491, 87591, and 87661 to be part of a laboratory panel grouping. When two or more of single test laboratory procedure codes are reported on a claim by the same provider on the same date of service, the codes will be bundled into the comprehensive laboratory procedure code 87801. Anthem will reimburse the more comprehensive, multiple organism CPT ®code 87801 when two or more single tests are billed separately by the same provider on the same date of service. Reimbursement will be made based on a single unit of CPT® code 87801 regardless of the units billed for a single code. The provider is required to bill for the applicable single STI CPT codes as rendered and the comprehensive CPT code will be reimbursed. Modifiers will not override this edit.
For more information about this policy, visit the Reimbursement Policies page at anthem.com/provider.
Material adverse change (MAC)
Beginning with dates of service on or after December 1, 2021, Anthem Blue Cross and Blue Shield (Anthem) will update the policy to indicate that separate reimbursement is not allowed for specimen validity testing when utilized for drug screening because it is included in the CPT and HCPCS code descriptions for presumptive and definitive drug testing. Modifiers will not override this edit; therefore, we have included this information in our Distinct Procedural Services (Modifiers 59, XE, XP, XS, XU) reimbursement policy.
For more information about this policy, visit the Reimbursement Policies page at anthem.com/provider.
RETRACTION: This policy has been retracted. View the retraction notice published in the December 2021 issue of Provider News.
Material adverse change (MAC)
Beginning with dates of service on or after December 1, 2021, Anthem Blue Cross and Blue Shield (Anthem) will implement a new reimbursement policy titled Inpatient Facility Transfers. The policy addresses inpatient transfers from one acute care facility to another acute care facility for the same episode of care. Anthem allows reimbursement for services rendered by both the transferring and the receiving facility.
For more information about this policy, visit the Reimbursement Policies page at anthem.com/provider.
Material adverse change (MAC)
Prior authorization updates
Effective for dates of service on and after December 1, 2021, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our prior authorization review process.
Please note, inclusion of National Drug Code (NDC) code on your claim will help expedite claim processing of drugs billed with a Not Otherwise Classified (NOC) code.
To access the Clinical Criteria information, click here.
Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by the medical specialty drug review team. Review of specialty pharmacy drugs for oncology use is managed by AIM Specialty Health® (AIM).
Clinical Criteria
|
HCPCS or CPT Code(s)
|
Drug
|
**ING-CC-0201
|
J9999
|
Rybrevant
|
* Non-oncology use is managed by the medical specialty drug review team.
** Oncology use is managed by AIM.
Quantity limit updates
Effective for dates of service on and after December 1, 2021, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our quantity limit review process.
Please note, inclusion of National Drug Code (NDC) code on your claim will help expedite claim processing of drugs billed with a Not Otherwise Classified (NOC) code.
To access the Clinical Criteria information, click here.
Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by the medical specialty drug review team. Review of specialty pharmacy drugs for oncology use is managed by AIM Specialty Health® (AIM).
Clinical Criteria
|
HCPCS or CPT Code(s)
|
Drug
|
*ING-CC-0050
|
J3490, J3590
|
Skyrizi
|
*ING-CC-0075
|
Q5123
|
Riabni
|
* Non-oncology use is managed by the medical specialty drug review team.
** Oncology use is managed by AIM.
Medicare Advantage
Policy Update
DRG Inpatient Facility Transfers
Effective 11/30/21
Effective 11/30/21, Anthem Blue Cross and Blue Shield claims for members who leave against medical advice and are admitted to another acute care facility on the same day are considered transfers and will follow the criteria detailed in the policy.
For additional information, please review the DRG Inpatient Facility Transfers reimbursement policy at anthem.com/medicareprovider under the Facilities dropdown.
Medicare Advantage
The best way to ensure you're submitting everything needed for a prior authorization is to use the prior authorization/precertification form at anthem.com/medicareprovider > Providers > Provider Resources > Forms and Guides. By filling out the form completely and with as much information as possible, you can be sure we have the information to process your request timely.
Medicare Advantage
On November 1, 2021, Anthem Blue Cross and Blue Shield (Anthem) prior authorization (PA) requirements will change for L8702 covered by Anthem. Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.
PA requirements will be added for the following code:
- L8702 — Powered upper extremity range of motion assist device, elbow, wrist, hand, finger, single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated
Not all PA requirements are listed here. Detailed PA requirements are available to contracted providers on the provider website at anthem.com/provider/news/archives/?cnslocale=en_US_co&category=medicareadvantage > Login or by accessing Availity.* Once logged in to Availity, select Patient Registration > Authorizations & Referrals, then choose Authorizations or Auth/Referral Inquiry, as appropriate. Contracted and noncontracted providers who are unable to access Availity may call our Provider Services at the number on the back of your patients’ Anthem ID card for assistance with PA requirements.
|